Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.50 |
| ▸ | KDM4A | O75164 | 1/20 | 0.50 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.50 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.50 |
| ▸ | FNTA | P49354 | 4/20 | 0.45 |
| ▸ | FNTB | P49356 | 4/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2148740 | 1.00 | KDM4C (0.50) | KDM4CKDM4APHF8KDM2AFNTA | |
| SCHEMBL2904418 | 1.00 | KDM4C (0.50) | KDM4CKDM4APHF8KDM2AFNTA | |
| SCHEMBL5720556 | 1.00 | KDM4C (0.50) | KDM4CKDM4APHF8KDM2AFNTA | |
| SCHEMBL1053609 | 1.00 | KDM4C (0.50) | KDM4CKDM4APHF8KDM2AFNTA | |
| SCHEMBL687882 | 1.00 | KDM4C (0.50) | KDM4CKDM4APHF8KDM2AFNTA | |
| SCHEMBL5720596 | 1.00 | KDM4C (0.50) | KDM4CKDM4APHF8KDM2AFNTA | |
| SCHEMBL689111 | 1.00 | KDM4C (0.50) | KDM4CKDM4APHF8KDM2AFNTA | |
| SCHEMBL690967 | 1.00 | KDM4C (0.50) | KDM4CKDM4APHF8KDM2AFNTA | |
| SCHEMBL690966 | 1.00 | KDM4C (0.50) | KDM4CKDM4APHF8KDM2AFNTA | |
| SCHEMBL14672444 | 1.00 | KDM4C (0.50) | KDM4CKDM4APHF8KDM2AFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1368057-B1 | METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN | TORREY PINES INST (US) | 2009-08-26 | — | — | EP | claimed |
| US-7229621-B2 | Method to enhance the immunogenicity of an antigen | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 2007-06-12 | — | — | US | claimed |
| EP-1071411-B1 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INST (US) | 2007-03-14 | — | — | EP | claimed |
| EP-1071411-A4 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INST (US) | 2004-12-08 | — | — | EP | claimed |
| EP-1368057-A2 | METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN | Lancell, Llc (US) | 2003-12-10 | — | — | EP | claimed |
| WO-2002074332-A2 | METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN | LANCELL, LLC (US) | 2002-09-26 | — | — | WO | claimed |
| US-20010024649-A1 | Method to enhance the immunogenicity of an antigen | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 2001-09-27 | — | — | US | claimed |
| US-6210672-B1 | TOPICAL ADMINISTRATION OF AN ANTIGEN OR A PORTION THEREOF IN CONJUNCTION WITH AN ENHANCER OF SKIN PENETRATION AND AN INDUCER OF LANGERHANS CELL MIGRATION. | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 2001-04-03 | — | — | US | claimed |
| EP-1071411-A1 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 2001-01-31 | — | — | EP | claimed |
| WO-1999053912-A1 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 1999-10-28 | — | — | WO | claimed |
| EP-2554049-B1 | Herbicidal composition with improved efficiency, preparation method and use | ARD SA (FR) | 2016-03-02 | — | — | EP | disclosed |
| US-20150307938-A1 | METHOD TO IDENTIFY A NOVEL CLASS OF IMMUNOLOGIC ADJUVANTS | LANCELL L L C (US) | 2015-10-29 | — | — | US | disclosed |
| EP-2554049-A1 | Herbicidal composition with improved efficiency, preparation method and use | AGRO INDUSTRIE RECHERCHES ET DEVELOPPEMENTS (A.R.D.) (FR) | 2013-02-06 | — | — | EP | disclosed |
| WO-2012138928-A1 | METHOD TO IDENTIFY A NOVEL CLASS OF IMMUNOLOGIC ADJUVANTS | LANCELL, L.L.C. (US) | 2012-10-11 | — | — | WO | disclosed |
| US-20120258125-A1 | METHOD TO IDENTIFY A NOVEL CLASS OF IMMUNOLOGIC ADJUVANTS | LANCELL, L.L.C. (US) | 2012-10-11 | — | — | US | disclosed |
| EP-1071411-B1 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INST (US) | 2007-03-14 | — | — | EP | disclosed |
| EP-1368057-A2 | METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN | Lancell, Llc (US) | 2003-12-10 | — | — | EP | disclosed |
| WO-2002074332-A2 | METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN | LANCELL, LLC (US) | 2002-09-26 | — | — | WO | disclosed |
| US-20010024649-A1 | Method to enhance the immunogenicity of an antigen | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 2001-09-27 | — | — | US | disclosed |
| US-6210672-B1 | TOPICAL ADMINISTRATION OF AN ANTIGEN OR A PORTION THEREOF IN CONJUNCTION WITH AN ENHANCER OF SKIN PENETRATION AND AN INDUCER OF LANGERHANS CELL MIGRATION. | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 2001-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010024649-A1 | Method to enhance the immunogenicity of an antigen | CD69, CD74, LY96 | KDM4C 2306/4885KDM4A 2189/4885PHF8 2740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.